Women's Health market research reports by GBI Research

Global Women’s Health Drugs Market to 2024 - Influx of New Products Including Orilissa, Relugolix and Bremelanotide to Diversify Landscape and Drive Growth

Jan 01, 2019  |  Published by: GBI Research  |  USD 4,995

Global Women’s Health Drugs Market to 2024 - Influx of New Products Including Orilissa, Relugolix and Bremelanotide to Diversify Landscape and Drive Growth Summary The women’s health market represents a small but growing therapy area. There are currently 277 pipeline products in active development f ... Read More